Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
depot leuprolide + estrogen + progestin
- Development stage
- Unknown
- Lead developer
- University of Chicago
- Modality
- Peptides, Small Molecules
- Administration
- Intramuscular, Transdermal
01
Overview
This combination therapy is used in clinical research settings to study the effects of hormonal suppression and replacement in women with Polycystic Ovary Syndrome (PCOS). It consists of depot leuprolide, a gonadotropin-releasing hormone (GnRH) agonist that temporarily suppresses the hypothalamic-pituitary-ovarian axis to reduce endogenous production of estrogen and testosterone. To prevent symptoms of hormone deficiency and maintain physiological female hormone levels, it is co-administered with exogenous estrogen and progestin (typically via a transdermal patch). This "add-back" regimen allows researchers to isolate the effects of hyperandrogenism or other PCOS-related factors while maintaining a controlled hormonal environment.
- Brand names
- Lupron
- Other names
- depot leuprolide plus estrogen/progestin replacement
02
Targets
PR (Progesterone receptor)GnRHR (Gonadotropin-releasing hormone receptor)ER (Estrogen receptor)
Beyond the preview
Go deeper on depot leuprolide + estrogen + progestin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on depot leuprolide + estrogen + progestin.